Acne Vulgaris
532
18
29
393
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
177 trials with published results (33%)
Research Maturity
393 completed trials (74% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
2.1%
11 terminated out of 532 trials
97.3%
+10.8% vs benchmark
37%
195 trials in Phase 3/4
45%
177 of 393 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 393 completed trials
Clinical Trials (532)
Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris
Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris
Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial
Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study
A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris
A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1)
A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)
A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)
1% Clascoterone Cream for the Treatment Acne Vulgaris
A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.
Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)
Lipidome and Microbiome Profile of Acne
Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris
Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients